What is Disc Medicine's other commercial liabilities?

Disc Medicine (IRON) reported other commercial liabilities of $6.83M in Q1 2026.

How has Disc Medicine's other commercial liabilities changed year-over-year?

Disc Medicine's other commercial liabilities increased by 65.0% year-over-year, from $4.14M to $6.83M.

What is the long-term trend for Disc Medicine's other commercial liabilities?

Over 5 years (2020 to 2025), Disc Medicine's other commercial liabilities has grown at a 99.5% compound annual growth rate (CAGR), from $492.59K to $15.56M.

Disc Medicine IRON Other Commercial Liabilities

Other Commercial Liabilities at other companies

Vertex PharmaceuticalsVRTX

——

Agios PharmaceuticalsAGIO

——

Travere Therapeutics, Inc.TVTX

——

Other financials

Income statement

See full

Operating income-$69.5M-74.0%

Net income-$63.5M-86.3%

EPS (diluted)-$1.65-61.8%

Balance sheet

See full

Cash & equivalents$88.9M-27.5%

Total debt$31.1M+1.4%

Total equity$688.4M+4.3%

Total assets$750.2M+5.8%

Cash flow

See full

Operating cash flow-$62.2M-50.4%

CapEx--100%

Free cash flow-$62.2M-47.4%

Valuation

See full

Market cap$2.69B+42.2%

Enterprise value$2.63B+46.7%

Returns & leverage

See full

Return on equity-35.8%+41.3pp

Debt / equity0×0.0×

Current ratio24×-13.6×

Where this comes from

Reported directly by Disc Medicine in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: Disc Medicine’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Disc Medicine's other commercial liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Disc Medicine's other commercial liabilities?: Disc Medicine (IRON) reported other commercial liabilities of $6.83M in Q1 2026.
How has Disc Medicine's other commercial liabilities changed year-over-year?: Disc Medicine's other commercial liabilities increased by 65.0% year-over-year, from $4.14M to $6.83M.
What is the long-term trend for Disc Medicine's other commercial liabilities?: Over 5 years (2020 to 2025), Disc Medicine's other commercial liabilities has grown at a 99.5% compound annual growth rate (CAGR), from $492.59K to $15.56M.